Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| PI 14/00392 | Other Grant/Funding Number | Instituto de Salud Carlos III |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Hospital Clinic of Barcelona | OTHER |
| Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | OTHER |
| Germans Trias i Pujol Hospital | OTHER |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
In the last years, important advances have been done in the treatment and prevention of fundal variceal bleeding in patients with cirrhosis. Experts agree that the combination of pharmacological and endoscopic therapy (with tissue adhesives) should be the first line therapy in the acute bleeding episode from isolated gastric varices (IGV1) or type 2 gastroesophageal varices (GOV2) varices; whereas transjugular intrahepatic portosystemic shunt (TIPS) is considered a rescue therapy. TIPS has been shown to effectively prevent variceal rebleeding but with a potential increase in the incidence of hepatic encephalopathy and/or liver failure. In this sense, a recent randomized controlled trial (RCT) in esophageal variceal bleeding showed that an early TIPS, performed during the first 72h after patient admission resulted in a significant decrease in failure to control bleeding and early and late rebleeding. Moreover, survival was also significantly increased as well as other portal-hypertension related complications (ascites, spontaneous bacterial peritonitis, hepatorenal syndrome, etc).
The present study is directed at comparing the outcome of patients with acute bleeding from fundal varices (IGV1 or GOV2) treated by standard therapy (vasoactive drugs + endoscopic injection of tissue adhesives) with or without early TIPS (performed during the first 1-5 days after admission). Main end-point will be survival free of variceal rebleeding at 1 year from inclusion.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Early TIPS | Active Comparator | Standard treatment to achieve initial hemostasis: vasoactive drugs (somatostatin or terlipressin) + endoscopic injection of tissue adhesives according to the center protocol. Performance of TIPS in the first 5 days following acute gastric variceal bleeding. |
|
| Control | Placebo Comparator | Standard treatment to achieve initial hemostasis: vasoactive drugs (somatostatin or terlipressin) + endoscopic injection of tissue adhesives according to the center protocol. Standard combined endoscopic and pharmacological therapy as a secondary prophylaxis (beta-blockers or carvedilol + repeated injection of tissue adhesives until the erradication of the fundal varices). |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Early TIPS | Device | TIPS (first 5 days) |
|
| Measure | Description | Time Frame |
|---|---|---|
| Combined: Absence of rebleeding + survival | The primary endpoint combines absence of rebleeding + survival during the first 1 year after inclusion in the study. Patients to compare are those with liver cirrhosis and acute bleeding from IGV1 or GOV2 varices initially treated with combined pharmacological and endoscopic therapy. Those patients will be randomized to receive a TIPS or standard medical therapy (pharmacological + endoscopic injection of tissue adhesives) | 1 year |
| Measure | Description | Time Frame |
|---|---|---|
| Absence of portal hypertension-related complications (ascites, spontaneous bacterial peritonitis, hepatorenal syndrome) | Comparison of the development of portal-hypertension related complications. | 6 weeks and 1 year |
| Transfusional requirements |
Not provided
Inclusion Criteria:
Patients developing acute variceal bleeding from GOV2 and/or IGV1 defined according to Baveno II criteria, admitted in the Hospital and receiving standard combined medical therapy (somatostatin 3 mg/12h continuous IV infusion or terlipressin, 2mg/4h IV + endoscopic injection of tissue adhesives as per center protocol).
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Angels Escorsell, MD | Contact | 34932275400 | 4030 | aescor@clinic.cat |
| Name | Affiliation | Role |
|---|---|---|
| Angels Escorsell, MD | Senior Consultant. Liver Unit | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Hospital Germans Trias i Pujol | Recruiting | Badalona | Catalonia | Spain |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 17879356 | Background | Garcia-Tsao G, Sanyal AJ, Grace ND, Carey W; Practice Guidelines Committee of the American Association for the Study of Liver Diseases; Practice Parameters Committee of the American College of Gastroenterology. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Hepatology. 2007 Sep;46(3):922-38. doi: 10.1002/hep.21907. No abstract available. | |
| 18435460 |
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D006975 | Hypertension, Portal |
| ID | Term |
|---|---|
| D008107 | Liver Diseases |
| D004066 | Digestive System Diseases |
Not provided
Not provided
| Hospital Universitario Ramon y Cajal |
| OTHER |
| Hospital del Mar | OTHER |
Not provided
Not provided
Not provided
Not provided
Not provided
We will compare the number of packed red blood cells required by each treatment arms as a surrogate of rebleeding.
| 6 weeks and 1 year |
| Individual adverse events | Related and not related to the therapies under study. | 1 year |
| Hospital stay | Including the stay for the index bleed and also readmissions due to complications of liver disease. | 1 year |
| Use of hospital resources | Use of hospital resources other than specified in the treatment arms (TIPS, revision of TIPS patency, derivative surgery or additional endoscopic therapy). | 1 year |
| ICU Liver Unit. Hospital Clinic of Barcelona | Recruiting | Barcelona | Catalonia | 08036 | Spain |
|
| Hospital de la Santa Creu i Sant Pau | Recruiting | Barcelona | Catalonia | Spain |
|
| Hospital del Mar | Recruiting | Barcelona | Catalonia | Spain |
|
| Hospital Arnau de Vilanova | Recruiting | Lleida | Spain |
|
| Background |
| Garcia-Tsao G, Bosch J, Groszmann RJ. Portal hypertension and variceal bleeding--unresolved issues. Summary of an American Association for the study of liver diseases and European Association for the study of the liver single-topic conference. Hepatology. 2008 May;47(5):1764-72. doi: 10.1002/hep.22273. No abstract available. |
| 20573925 | Result | Garcia-Pagan JC, Caca K, Bureau C, Laleman W, Appenrodt B, Luca A, Abraldes JG, Nevens F, Vinel JP, Mossner J, Bosch J; Early TIPS (Transjugular Intrahepatic Portosystemic Shunt) Cooperative Study Group. Early use of TIPS in patients with cirrhosis and variceal bleeding. N Engl J Med. 2010 Jun 24;362(25):2370-9. doi: 10.1056/NEJMoa0910102. |